These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37905361)

  • 1. Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure.
    Ter Maaten JM; Mebazaa A; Davison B; Edwards C; Adamo M; Arrigo M; Barros M; Biegus J; Čelutkienė J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Leopold V; Novosadova M; Pagnesi M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Tomasoni D; Metra M; Cotter G; Voors AA
    Eur J Heart Fail; 2023 Dec; 25(12):2230-2242. PubMed ID: 37905361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial.
    Tomasoni D; Davison B; Adamo M; Pagnesi M; Mebazaa A; Edwards C; Arrigo M; Barros M; Biegus J; Čelutkienė J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Novosadova M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Maaten JMT; Voors A; Cotter G; Metra M
    J Card Fail; 2024 Apr; 30(4):525-537. PubMed ID: 37820896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk.
    Ambrosy AP; Chang AJ; Davison B; Voors A; Cohen-Solal A; Damasceno A; Kimmoun A; Lam CSP; Edwards C; Tomasoni D; Gayat E; Filippatos G; Saidu H; Biegus J; Celutkiene J; Ter Maaten JM; Čerlinskaitė-Bajorė K; Sliwa K; Takagi K; Metra M; Novosadova M; Barros M; Adamo M; Pagnesi M; Arrigo M; Chioncel O; Diaz R; Pang PS; Ponikowski P; Cotter G; Mebazaa A
    JACC Heart Fail; 2024 May; ():. PubMed ID: 38739123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.
    Cotter G; Deniau B; Davison B; Edwards C; Adamo M; Arrigo M; Barros M; Biegus J; Celutkiene J; Cerlinskaite-Bajore K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pang PS; Pagnesi M; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Tomasoni D; Voors A; Mebazaa A
    JAMA Cardiol; 2024 Feb; 9(2):114-124. PubMed ID: 38150260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
    Mebazaa A; Davison B; Chioncel O; Cohen-Solal A; Diaz R; Filippatos G; Metra M; Ponikowski P; Sliwa K; Voors AA; Edwards C; Novosadova M; Takagi K; Damasceno A; Saidu H; Gayat E; Pang PS; Celutkiene J; Cotter G
    Lancet; 2022 Dec; 400(10367):1938-1952. PubMed ID: 36356631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial.
    Čerlinskaitė-Bajorė K; Lam CSP; Sliwa K; Adamo M; Ter Maaten JM; Léopold V; Mebazaa A; Davison B; Edwards C; Arrigo M; Barros M; Biegus J; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Metra M; Novosadova M; Pagnesi M; Pang PS; Ponikowski P; Saidu H; Takagi K; Tomasoni D; Voors AA; Cotter G; Čelutkienė J
    Eur J Heart Fail; 2023 Jul; 25(7):1156-1165. PubMed ID: 37191154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial.
    Pagnesi M; Vilamajó OAG; Meiriño A; Dumont CA; Mebazaa A; Davison B; Adamo M; Arrigo M; Barros M; Biegus J; Celutkiene J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Edwards C; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Novosadova M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Tomasoni D; Voors AA; Cotter G; Metra M
    Eur J Heart Fail; 2024 Mar; 26(3):638-651. PubMed ID: 38444216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trial.
    Arrigo M; Biegus J; Asakage A; Mebazaa A; Davison B; Edwards C; Adamo M; Barros M; Celutkiene J; Čerlinskaitė-Bajorė K; Chioncel O; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pagnesi M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Tomasoni D; Voors AA; Cotter G; Cohen-Solal A
    Eur J Heart Fail; 2023 Jul; 25(7):1145-1155. PubMed ID: 37246591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial.
    Adamo M; Pagnesi M; Mebazaa A; Davison B; Edwards C; Tomasoni D; Arrigo M; Barros M; Biegus J; Celutkiene J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Novosadova M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Voors A; Cotter G; Metra M
    Eur Heart J; 2023 Aug; 44(31):2947-2962. PubMed ID: 37217188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial.
    Arrigo M; Davison B; Edwards C; Adamo M; Ambrosy AP; Barros M; Biegus J; Celutkiene J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pagnesi M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Tomasoni D; Voors AA; Cotter G; Mebazaa A
    Am Heart J; 2024 Aug; 274():119-129. PubMed ID: 38740532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
    J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF.
    Biegus J; Mebazaa A; Davison B; Cotter G; Edwards C; Čelutkienė J; Chioncel O; Cohen-Solal A; Filippatos G; Novosadova M; Sliwa K; Adamo M; Arrigo M; Lam CSP; Ter Maaten JM; Deniau B; Barros M; Čerlinskaitė-Bajorė K; Damasceno A; Diaz R; Gayat E; Kimmoun A; Pang PS; Pagnesi M; Saidu H; Takagi K; Tomasoni D; Voors AA; Metra M; Ponikowski P
    J Am Coll Cardiol; 2024 Jul; 84(4):323-336. PubMed ID: 39019527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
    Izumi K; Kohno T; Goda A; Takeuchi S; Shiraishi Y; Saji M; Nagatomo Y; Tanaka TD; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
    Int J Cardiol; 2023 Jan; 370():255-262. PubMed ID: 36270494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-renal-metabolic syndrome: clinical features and dapagliflozin eligibility in a real-world heart failure cohort.
    Beles M; Masuy I; Verstreken S; Bartunek J; Dierckx R; Heggermont W; Oeste C; De Boeck M; Fovel I; Maris M; Vermeulen Z; Vanderheyden M
    ESC Heart Fail; 2023 Aug; 10(4):2269-2280. PubMed ID: 37095712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study.
    Kimmoun A; Cotter G; Davison B; Takagi K; Addad F; Celutkiene J; Chioncel O; Solal AC; Diaz R; Damasceno A; Duengen HD; Filippatos G; Goncalvesova E; Merai I; Metra M; Ponikowski P; Privalov D; Sliwa K; Sani MU; Voors AA; Shogenov Z; Mebazaa A
    Eur J Heart Fail; 2019 Nov; 21(11):1459-1467. PubMed ID: 31423712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Modeling Analysis of an Intensive GDMT Optimization Program in Hospitalized Heart Failure Patients.
    Dixit NM; Parikh NU; Ziaeian B; Fonarow GC
    Circ Heart Fail; 2023 Dec; 16(12):e011218. PubMed ID: 37929591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry.
    Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G
    Eur J Heart Fail; 2023 Jul; 25(7):1132-1144. PubMed ID: 37317585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).
    Vardeny O; Wu DH; Desai A; Rossignol P; Zannad F; Pitt B; Solomon SD;
    J Am Coll Cardiol; 2012 Nov; 60(20):2082-9. PubMed ID: 23083787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.